Abbott Laboratories (ABT) Q3 2016 Earnings Results

Abbott Laboratories Beats on EPS, Stock Down 2.82%

Abbott Laboratories reported an EPS that exceeded expectations, but the stock fell by 2.82% in reaction. This decline may reflect investor concerns or broader market trends, as there was no revenue figure provided and no guidance updates were shared.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.59	N/A	+1.55%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Abbott Laboratories Beats on EPS, Stock Down 2.82%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Laboratories Beats on EPS, Stock Down 2.82%

Key numbers

Management commentary